Sutro Biopharma Depreciation & Amortization 2011-2026 | STRO

Annual Depreciation & Amortization Sutro Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.32 M	7.22 M	6.82 M	5.69 M	4.84 M	4.3 M	4.78 M	4.54 M	4.99 M	5.66 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.32 M	4.3 M	5.62 M

Quarterly Depreciation & Amortization Sutro Biopharma

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	1.9 M	-	-	-	1.76 M	-	-	-	1.62 M	-	4.16 M	2.72 M	1.33 M	-	3.53 M	2.41 M	1.29 M	-	3.12 M	2.16 M	1.1 M	-	3.56 M	2.33 M	1.14 M	-	3.4 M	2.28 M	1.16 M	-	3.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.16 M	1.1 M	2.36 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 9.13	-0.76 %	$ 591 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptorum Group Limited APM	1.13 M	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	186 K	$ 15.52	-2.39 %	$ 49.6 M	USA
ACADIA Pharmaceuticals ACAD	920 K	$ 22.47	1.19 %	$ 3.72 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Fortress Biotech FBIO	403 K	$ 2.24	0.9 %	$ 62.5 M	USA
Galectin Therapeutics GALT	1 K	$ 2.26	0.22 %	$ 144 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 31.01	-0.13 %	$ 1.78 B	USA
ImmuCell Corporation ICCC	2.78 M	$ 8.44	-	$ 76.2 M	USA
Incyte Corporation INCY	93.3 M	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	202 K	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	84 K	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	26.3 M	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	1.91 M	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	969 K	$ 26.67	-0.02 %	$ 1.44 B	Britain
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Ligand Pharmaceuticals Incorporated LGND	35.2 M	$ 223.98	-0.39 %	$ 4.1 B	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.22	7.69 %	$ 5.3 M	Israel
Liquidia Corporation LQDA	1.53 M	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	548 K	$ 4.08	0.74 %	$ 436 M	USA